Brand Name: Tropicacyl Plus Eye Drop
Active Ingredients:
✔ Tropicamide 0.8% w/v (Anticholinergic)
✔ Phenylephrine 5% w/v (Alpha-adrenergic agonist)
Drug Class: Mydriatic & Cycloplegic Agent
Manufactured By: Sunways (India) Pvt. Ltd.
Packing Details: 5ml sterile dropper bottle.
Description:
Tropicacyl Plus Eye Drop is a combination medication used to dilate (enlarge) the pupil and temporarily paralyze the eye’s focusing muscles. It is commonly used before eye examinations, surgeries, and certain eye conditions where pupil dilation is required.
Uses:
✔ Mydriasis (pupil dilation) for eye examinations
✔ Cycloplegia (temporary paralysis of eye muscles)
✔ Pre-surgical eye preparation
✔ Treatment of eye inflammation & uveitis (as prescribed by a doctor)
Dosage & Administration:
-
For Eye Examination: 1-2 drops in the affected eye(s) 15-30 minutes before the procedure.
-
For Uveitis or Inflammation: Use as directed by a doctor.
-
Route of Administration: Ophthalmic (for external eye use only)
-
Missed Dose: Apply as soon as remembered, but avoid double dosing.
Side Effects:
✔ Temporary blurred vision
✔ Mild eye discomfort or stinging
✔ Increased light sensitivity
✔ Dry mouth or drowsiness (rare)
Serious side effects (seek medical attention immediately):
⚠ Severe allergic reaction (swelling, difficulty breathing)
⚠ Sudden eye pain, vision changes
⚠ Fast or irregular heartbeat
Precautions & Warnings:
⚠ For ophthalmic use only – Do not ingest or use in ears.
⚠ May cause temporary blurred vision – Avoid driving or operating machinery after use.
⚠ Use with caution in patients with glaucoma, high blood pressure, or heart disease.
⚠ Pregnant or breastfeeding women should consult a doctor before use.
Storage Instructions:
✔ Store at room temperature (below 30°C), away from sunlight and moisture.
✔ Keep bottle tightly closed when not in use.
✔ Keep out of reach of children.
Disclaimer:
This information is for educational purposes only. Always consult a doctor before using Tropicacyl Plus Eye Drop (5ml).
Reviews
There are no reviews yet.